Market Research News

Thursday, 28 September 2017

Erythropoietin (EPO) Drugs Market Estimated to reach USD 17.4 billion by 2025 : Grand View Research,Inc.

Global Erythropoietin (EPO)Drugs Market is expected to reach USD 17.4 billion by 2025, according to a new report by Grand View Research, Inc. Rising incidence of chronic diseases such as CKD and cancer resulting in anaemia is a major growth driver of this market.

According to the statistics published by the National Heart, Lung, and Blood Institute of the U.S. Department of Health & Human Services, over 3 million people are affected by anemia every year and this number is expected to increase over the forecast period. This showcases the need for erythropoietin-stimulating agents in the coming years.

Introduction of novel drugs and their cheaper biosimilar formulations with enhanced efficacy and cost-effectiveness is also expected to serve this industry with lucrative opportunities. For instance, development of numerous biosimilars in the European market is expected to gain traction and increase their usage rates, owing to associated benefits such as less time required for approval, cost-efficiency, and enhanced therapeutic effect.

Companies are involved in extensive R&D initiatives for development of innovative molecules and discovering new therapeutic areas for existing drugs. For instance, in April 2016, Sandoz received approval from the European Commission for use of its biosimilar Binocrit in nephrology indications, thereby extending the therapeutic area of its product portfolio.

Moreover, many of the industry players in the U.S., Europe, and Asia Pacific are involved in the development of new biosimilars. For example, Biocon’s subsidiary Syngene International entered into an agreement with Bristol-Myers Squibb to extend their drug discovery and development program in India. This enables Biocon to enhance its erythropoietin drugs portfolio. Expected product approvals in the coming years are anticipated to fuel market growth.

Full Research Report on Global Erythropoietin Drugs Market Analysis:
http://www.grandviewresearch.com/industry-analysis/erythropoietin-epo-drugs-market

Further key findings from the study suggest:

The biologics segment is declining over the forecast period owing to patent expiration of branded biologics and introduction of biosimilars in the market
The patent for Aranesp (darbepoetin-alfa) will expire in 2024 in the U.S. and is expected to provide numerous future growth opportunities for new market entrants
Epoetin-alfa held the largest share of product segment owing to its early introduction in the U.S. market and patent protection
Epoetin-omega and epoetin-zeta are anticipated to exhibit lucrative growth over the forecast period owing to associated benefits such as longer half-life and enhanced therapeutic effects
Use of erythropoietin drugs for treatment of renal diseases held a dominant share as of 2016 owing to the increasing incidence of chronic kidney diseases
The Asia Pacific regional industry for erythropoietin-stimulating agents is expected to witness lucrative CAGR during the forecast period
Industry participants are focusing on the discovery of new therapeutic areas for existing drugs and development of cost-effective biosimilars, thereby increasing R&D activities for the development of erythropoietin drugs.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Global Erythropoietin (EPO) Drugs Market on the basis of the drug class, product, application, and region:

Erythropoietin Drugs Drug class Outlook (Revenue, USD Million, 2014 - 2025)

Biologics
Biosimilar

Erythropoietin Drugs Product Outlook (Revenue, USD Million, 2014 - 2025)

Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others

Erythropoietin Drugs Application Outlook (Revenue, USD Million, 2014 - 2025)

Cancer
Hematology
Renal Diseases
Neurology

Erythropoietin Drugs Regional Outlook (Revenue, USD Million, 2014 - 2025)

North America

U.S.
Canada

Europe

Germany
UK

Asia Pacific

Japan
China
India

Latin America

Brazil
Mexico

South Africa

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-erythropoietin-epo-drugs-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Disposable Medical Sensors Market Projected to reach USD 12.3 billion by 2025 : Grand View Research,Inc.

Global Disposable MedicalSensors Market is expected to reach USD 12.3 billion by 2025, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic diseases has been observed to be a major factor driving growth which is demanding for better healthcare service provision by high quality diagnostic and monitoring devices. These devices will enable patients to self-monitor and along with easy and affordable usage. In addition, the rapidly rising technological advancements is expected to bring in innovation in medical sensors.

The market is also being driven by government initiatives to fund and encourage R&D which in turn will help in launching innovative products. For instance, the government of India increased the health expenditure from 1.4% to 2.5% for innovations, and other healthcare services. Innovations in medical sensors not only instill ease of use but also assist in making the device portable and automated.

On the basis of product, the biosensor segment is accounted to be the spearhead in 2016 and is expected to maintain its dominance over the forecast period. This can be attributed to the rising demand for rapid and accurate diagnostic kit. Development of such diagnostic tools is expected to further create new growth opportunities for biosensors, thereby supporting growth of the disposable medical sensors market. Launching of new products are expected to fuel market growth. For instance, Raiing Medical launched wearable thermometer in 2016 that is rechargeable and waterproof. Similarly, MEMSIC Inc. launched new pressure sensor in 2017 which is used in breath detection.

Full Research Report on Global Disposable Medical Sensors Market Analysis: http://www.grandviewresearch.com/industry-analysis/disposable-medical-sensors-industry

Further Key Findings From the Report Suggest:

Globally, disposable medical sensors witnessed lucrative growth in 2016 and are expected to grow at a CAGR of 10.2% from 2017 to 2025
Biosensor segment has been observed to be the largest product segment in 2016 and is estimated to generate revenue of over USD 6.03 billion by 2025
On the basis of application, the diagnostic segment is expected to dominate the market space. This is attributed to the increasing incidence of various infectious and other chronic conditions, along with the growing awareness among the population.
The industry in Asia Pacific is expected to witness substantial growth over the next decade owing to the increasing incidence of diseases and the geriatric population with high unmet healthcare needs.
Some of the key players in this industry are Medtronic, Philips, GE Healthcare, OmniVision Technologies, Sensiorion AG, Smiths Medical, and Analog Devices.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Disposable Medical Sensors Market on the basis of product, distribution channel, end use, and region:

Product Outlook (Revenue, USD Million, 2014 - 2025)

Biosensors
Pressure sensors
Accelerometer sensors
Temperature sensors
Image sensors

Type Outlook (Revenue, USD Million, 2014 - 2025)

Strip sensors
Wearable sensors
Implantable sensors
Invasive sensors
Ingestible sensors

Application Outlook (Revenue, USD Million, 2014 - 2025)

Diagnostic
Therapeutic
Patient monitoring

Regional Outlook (Revenue, USD Million, 2014 - 2025)

North America

U.S.
Canada

Europe

Germany
U.K

Asia Pacific

China
Japan

Latin America

Brazil
Mexico

Middle East Asia

South Africa
Saudi Arabia

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-disposable-medical-sensors-market

Latin America Insulin market Projected to reach USD 3,760.7 million by 2020 : Grand View Research,Inc.

The Latin America Insulin market is expected to reach USD 3,760.7 million by 2020, according to a new study by Grand View Research, Inc. Growing prevalence of diabetes (type I and type II) coupled with government initiatives to develop insulin in markets such as Brazil by providing medical and financial aid to the population in the form of subsidies and the entrance of multinational companies such as Novo Nordisk, Sanofi Aventis, etc is expected to drive regional insulin market. Affordability of medicines is perceived to be a key challenge for market development, as a significant part of the population may not be able to afford the product.

In 2013, Type II applications lead the regional market, with revenue of USD 1,183.7 million and are expected to grow at a CAGR of 15.8 % from 2014 to 2020. Type I applications are expected to have faster growth, at an estimated CAGR of 20.3 % from 2014 to 2020.

Full Research Report on Global Erythropoietin Drugs Market Analysis:
http://www.grandviewresearch.com/industry-analysis/latin-merica-insulin-market

Further key findings from the study suggest:

· Long acting products dominated insulin demand in Latin America, with estimated revenue of USD 548.6 million in 2013. Other leading products include rapid acting and premixed analogs, with the latter expected to grow at a CAGR of 14.3 % from 2014 to 2020.

· In 2013, Analog was a dominant insulin source and is expected to grow at a CAGR of 17.7 % from 2014 to 2020.

· R&D initiatives, changing lifestyle affecting health of people specially children and growing rate of old aged (above 40) population are also expected to have a positive influence on market demand.

· In 2013, Brazil was the largest regional insulin market in terms of revenue, accounting for 38.0% share of Latin American demand, followed by Mexico and Argentina. Brazil insulin demand is estimated to grow at a fastest CAGR of 18.2 % from 2014 to 2020.

· Some of the key manufacturers in Latin American insulin market include Sanofi Aventis, Novo Nordisk, Nanjing Xinbai Pharmaceutical Co. Ltd, Takeda Pharmaceuticals, Eli Lilly and Company.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Asia Pacific Insulin market on the basis of product, application, source and region:

Insulin Product Outlook

· Rapid acting

· Long acting

· Premixed

· Premixed analog

· Short acting

· Intermediate acting

Insulin Application Outlook

· Type II and Other Diabetes

· Type I Diabetes

· Insulin Source Outlook

· Human Recombinant

· Analogs

Insulin Regional Outlook

· Brazil

· Argentina

· Chile

· Mexico

· Colombia

· Venezuela

· Peru

· Rest of Latin America

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/latin-america-insulin

Cell Line Development Market size is expected to reach USD 6.24 billion by 2022 : Grand View Research,Inc.

Global Cell Line DevelopmentMarket size is expected to reach USD 6.24 billion by 2022, according to a new report by Grand View Research, Inc. The Increasing demand for monoclonal antibodies and patent expiration of blockbuster biologics are expected to drive the cell line development industry over the forecast period.

Increasing prevalence of autoimmune diseases and cancer are likely to increase the demand for accurate and cost effective treatment options which is expected to render a positive impact on market growth. In addition, improving healthcare infrastructure, economic development and favorable government initiatives promoting the growth of the biotechnology industry are factors contributing towards the growth of the cell line development market.

Ongoing R&D for stable & authentic cell lines and the introduction of technologically advanced processes such as single use bioreactor and micro bioreactor for large scale bioproduction are further expected to provide this market with lucrative future growth opportunities.

Full Research Report On Global Cell Line Development Market Analysis:
http://www.grandviewresearch.com/industry-analysis/cell-line-development-market

Further key findings from the study suggest:

Reagent and media was the largest product market in 2014, owing to increasing number of cell culture procedures. Reagent and media are necessary components involved in cell line development procedures & cell culture and are cost intensive in nature. The market for reagent and media was valued at over 1.0 billion in 2014.
Mammalian cell lines were widely used as a source for cell line development in 2014, owing to associated advantages such as accurate complex protein expression nature, critical for the production of monoclonal antibodies, vaccines, and biologics.
Cell line development finds the largest application in the bioproduction of biologics, vaccines, Mabs, therapeutic proteins and biosimilars. Rising demand for monoclonal antibodies and vaccines are expected to boost the growth of this segment over the forecast period. The market for cell line development based bioproduction is also expected to witness lucrative growth of over 12.5% during the forecast period.
North America was the largest market in 2014, with revenue estimated at over 800 million. The region’s market dominance is attributed to factors such as the growing adoption rates of cell culture techniques, presence of well developed healthcare infrastructure, supportive government initiatives and high healthcare expenditure levels.
Asia Pacific cell line development market is anticipated to register rapid growth over the forecast period owing to factors such as the presence of high unmet needs, rising number of CROs (Contract Research Organization) providing pertinent services, growing R&D investments aimed at the development of stable cell lines and increasing biologics production.
Key players in this market include European Collection of cell Cultures (ECACC), Lonza Group AG, GE Healthcare, Thermo Fisher Scientific Inc., Sartorious AG, Selexis SA, Wuxi AppTec Inc., Sigma-Aldrich Corporation, American Type Culture Collection (ATCC) and Corning Inc.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/clinical-diagnostics

For the purpose of this study, Grand View Research has segmented the Global Cell Line Development Market on the basis of product, source, type of cell line, application and region:

Global Cell Line Development Product Outlook (Revenue, USD Million, 2012 - 2022)

· Reagents and media

· Equipment Accessories and consumables

§ Incubators

§ Centrifuges

§ Bioreactors

§ Storage equipment

§ Microscopes

Global Cell Line Development Source Outlook (Revenue, USD Million, 2012 - 2022)

· Mammalian

· Non mammalian

§ Insects

§ Amphibians

Global Cell Line Development Type Of Cell Line Outlook (Revenue, USD Million, 2012 - 2022)

· Recombinant cell lines

· Hybridomas

· Continuous cell line

· Primary cell lines

Global Cell Line Development Application Outlook (Revenue, USD Million, 2012 - 2022)

· Bioproduction

· Drug discovery

· Toxicity testing

· Tissue engineering

· Research

Cell Line Development Regional Outlook (Revenue, USD Billion, 2014 - 2022)

· North America

§ U.S.

§ Canada

· Europe

§ Germany

§ UK

· Asia Pacific

§ China

§ Japan

§ India

· Latin America

§ Mexico

§ Brazil

· MEA

§ South Africa

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-cell-line-development-market

Heat Transfer Fluids Market Expected to reach USD 3.68 billion by 2022 : Grand View Research,Inc.

Global Heat Transfer FluidsMarket is expected to reach USD 3.68 billion by 2022, according to a new study by Grand View Research, Inc. Imminent need to manage excessive heat in several manufacturing industries including automotive, metal processing, pharmaceuticals, and food processing is a major factor driving heat transfer fluid demand across the globe. Surging requirement for application specific fluids with optimum thermal coefficient is also anticipated to fuel industry growth over the forecast period. Rapid industrialization in BRICS markets is expected to help in market development over the forecast period.

Stringent environment regulations coupled with volatile raw material prices are expected to pose threat to industry profitability. Development of bio-based or water-based heat transfer fluids is anticipated to create lucrative opportunities for industry participants.

Silicone & aromatics formed the largest product segment with demand share exceeding 40% in 2014. The segment is expected to gain share over next seven years on account of increasing requirement for synthetic thermal oils in these applications is expected to drive the product market over the forecast period. Glycols are expected to witness maximum gains in its market size over the forecast period on account of excellent antifreeze properties.

Full Research Report on Global Heat Transfer Fluids Market Analysis:
http://www.grandviewresearch.com/industry-analysis/heat-transfer-fluids-market

Further key findings from the study suggest:

Global heat transfer fluids market demand was 465.9 kilo tons in 2014 and is expected to reach 745.3 kilo tons by 2022, growing at a CAGR of 6.1% from 2015 to 2022
Oil & gas was the leading application segment and accounted for 23.8% of total market volume in 2014. HTF demand in this segment is expected to witness a modest growth over the forecast period. Increasing use of heating oil in offshore oil & gas thermal processes is anticipated to fuel market growth.
CSP is expected to witness significant gains in its size over the forecast period on account of growing energy demand and favorable government initiatives particularly in Spain, U.S. and Middle East.
Europe was the largest regional market and accounted for over 30% of global demand in 2014. Power and energy sector is highly active in these regions owing to high energy requirements from industrial sectors. Large scale urbanization coupled with increased usage of automobiles is expected to steer the demand for coolants and other heat transfer fluids.
Asia Pacific is expected to witness the highest growth of 7.0% from 2015 to 2022 on account of growing chemical and food & beverage industry in China, India and Indonesia.
Major companies operating in global heat transfer fluids market include Dow Chemicals, Shell, ExxonMobil, Eastman Company, BASF, Huntsman Corporation, Chevron Corporation.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/petrochemicals-and-downstream-derivatives

Grand View Research has segmented the heat transfer Global Fluids Market on the basis of product, application and region:

Global Heat Transfer Fluids Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)

Silicone & Aromatics
Mineral Oils
Glycol-Based Fluids
Others

Global Heat Transfer Fluids Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)

Oil & Gas
Chemical
Concentrated Solar Power (CSP)
Food & Beverages
Plastics
Pharmaceuticals
Heating, Ventilating & Air Conditioning (HVAC)
Others

Global Heat Transfer Fluids Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)

North America

U.S.
Canada
Mexico

Europe

Germany
UK

Asia Pacific Middle East & Africa

China
India
Japan

Central & South America

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-heat-transfer-fluids-market

Metal Stamping Market Projected to reach USD 299.6 billion by 2025 : Grand View Research,Inc.

Global Metal Stamping Market is expected to reach USD 299.6 billion by 2025, according to a new report by Grand View Research, Inc. The increasing use of sheet metal in application industries such as automotive, industrial machinery, and consumer electronics is expected to drive industry growth.

Rising number of fabricators in Asia Pacific region is expected to be a key driving factor for the industry. The increasing R&D investment by companies to improve efficiency and operational-ability of stamping machinery is expected to promote growth over the forecast period.

Metal prices have seen constant fluctuations in the past few decades. The growing demand from end-use industries as well as economic growth and its subsequent decline has resulted in volatility in the prices. However, the prices witnessed an overall downfall in the recent past which is expected to aid the use of metal and stamping processes.

The stamping industry is highly competitive with a presence of companies catering to local as well as global market. Players in the industry compete on the basis of service, customized products and expertise in the manufacturing of stamped parts and sign a long-term agreement with the OEMs to ensure constant demand.

Full Research Report on Global Metal Stamping Market Analysis:
http://www.grandviewresearch.com/industry-analysis/metal-stamping-market

Further key findings from the report suggest:

Blanking is an integral part of the automobile manufacturing chain and is expected to witness significant growth in demand over the forecast period owing to its precise and superior blanking technologies introduced in the industry
The use of laser embossing for engraving patterns and dates on automotive components and on license plates is expected to augment the demand for the process and is projected to account for 22.2% by 2025
Metal stamping in automotive application to manufacture auto-body components such as tailgate, trunk lid, door, bonnet, and hood dominated the global market in 2016 and is expected to account for 33.2% of the overall revenue share in 2025
Consumer electronics is expected grow at a CAGR of 6.0% over the forecast period on account of the growing utilization of lightweight metal parts to enhance impact resistance of electronic components
Asia Pacific accounted for 34.8% of the overall revenue share in 2016 on account of the increased production of industrial machinery in Asian countries owing to favorable government initiatives to promote industrialization
Companies such as Alcoa have goodwill in the industry; which provides them with the leverage over the local manufacturers and has the ability to cater to the bulk requirements of the major players from application industries

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/hvac-and-construction-technologies

Grand View Research has segmented the Global Metal Stamping Market on the basis of process, application and region:

Metal Stamping Process Outlook (Revenue, USD Billion, 2014 - 2025)

Blanking
Embossing
Bending
Coining
Flanging
Others

Metal Stamping Application Outlook (Revenue, USD Billion, 2014 - 2025)

Automotive
Industrial Machinery
Consumer Electronics
Aerospace
Electrical & Electronics
Telecommunications
Others

Metal Stamping Regional Outlook (Revenue, USD Billion, 2014 - 2025)

North America

U.S.

Europe

Germany
U.K

Asia Pacific

China
India
Japan

Central & South America
Middle East & Africa

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-metal-stamping-market